Pharmaceuticals, Biotechnology and Life Sciences
The traditional R&D in the biopharmaceutical industry iswitnessing an upsurge, due to drug development research, which ishelping in the augmentation of the industrial microbiology market.
Eli Lilly’s Cyramza got its fifth FDA approval for in an advanced or metastatic cancer – this one for the second-line treatment of patients with hepatocellular carcinoma (HCC) who are AFP-High (AFP ≥400 ng/mL).
Newly discovered LEAPS conjugate vaccine acts alone and can complement CEL-4000 therapeutically when administered in combination to an animal model…
DUBLIN–(BUSINESS WIRE)–The “Bioinformatics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to…
— Proprietary Methylation Technology Selected for Continued Development of Multi-Cancer Test — — CCGA and STRIVE Studies Fully Enrolled with…
Annual HBA Woman of the Year event recognizes outstanding individuals and companies advancing the impact and influence of women in…
Transatlantic Charitable Partnership Aims to Meet the Needs of People Living with Cancer DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq:…
Clinical study to evaluate the potential of ORIC’s novel glucocorticoid receptor antagonist to be used in combination with Abraxane® SOUTH…
ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider…
Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…